- Reuters•last year
The antitrust division of the U.S. Department of Justice has subpoenaed Mylan N.V. for information relating to the pricing and marketing of its generic doxycycline antibiotic products, the drugmaker said on Friday. The Department of Justice has also sought information on any communication with competitors about the anti-bacterial products, the company said in a regulatory filing, adding it would cooperate with the federal agency. Competitors Endo International and Allergan Inc have also received similar subpoenas, according to regulatory filings made by them in November and August.
We're sorry this is all we were able to find about this topic.
SPARC.NS : Summary for SUN PHARMA ADV INR1 - Yahoo Finance
Sun Pharma Advanced Research Company Limited (SPARC.NS)
NSE - NSE Delayed Price. Currency in INR
Add to watchlist
|Day's Range||320.45 - 321.85|
|52 Week Range||254.37 - 414.90|
|PE Ratio (TTM)||-80.27|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|